(Q24812743)

English

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Anne-Lise Børresen-Dale

6

object named as

Anne-Lise Borresen-Dale

0 references

Jahn M. Nesland

4

object named as

Jahn M Nesland

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

7

object named as

Anne Dorum

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1

object named as

Pedro Kringen

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Gunnar B Kristensen

5

object named as

Gunnar Kristensen

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Vanessa Dumeaux

3

object named as

Vanessa Dumeaux

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

author name string

Yun Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

language of work or name

0 references

publication date

17 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1

0 references

134

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

7 April 2017

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

7 April 2017

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

7 April 2017

Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

7 April 2017

Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

7 April 2017

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

7 April 2017

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

7 April 2017

TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

28 September 2017

Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

28 September 2017

Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

28 September 2017

Molecular genetics of hereditary ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

28 September 2017

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

28 September 2017

Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

28 September 2017

Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic Cancer Registries.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

28 September 2017

A common BRCA1 mutation in Norwegian breast and ovarian cancer families?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

30 May 2018

A common BRCA1 mutation in the Ashkenazim.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

30 May 2018

A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-134

21 January 2018

Improved survival in women with BRCA-associated ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-134

21 January 2018

Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-134

21 January 2018

The IARC TP53 database: new online mutation analysis and recommendations to users

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-134

21 January 2018

Survival analysis in familial ovarian cancer, a case control study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-134

21 January 2018

TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-134

21 January 2018

Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-134

21 January 2018

Three per cent of Norwegian Ovarian Cancers are caused by BRCA1 1675delA or 1135insA

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-5-134

21 January 2018

Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

28 November 2018

Failure of BRCA1 dysfunction to alter ovarian cancer survival.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

28 November 2018

The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

28 November 2018

Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1276789

28 November 2018

Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis of 2,800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences between hereditary and sporadic ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased frequency ofTP53 mutations inBRCA1 andBRCA2 ovarian tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutation screening of the TP53 gene by temporal temperature gradient gel electrophoresis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Lung cancer in Norway. A review based on the Cancer Registry of Norway]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hereditary ovarian cancer. Heterogeneity in age at onset

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 gene mutation in human borderline epithelial ovarian tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of p53 in epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P53 mutation does not affect prognosis in ovarian epithelial malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993

1 reference

https://pubmed.ncbi.nlm.nih.gov/16229746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-5-134

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24812743&oldid=2177015553"